UBS analyst Colin Langan upgraded Lear Corporation to Buy and raised his price target for the shares to $143 from $141. The analyst sees less risk to the company's 2019 guidance since it already provided segment margin guidance. Further, Lear is currently trading at below four times EBITDA on the analyst's revised 2019 estimates, which he notes is at the low-end of historic ranges. In addition, the company has the best free cash flow yield in the group at 12%, which will support high share repurchases and/or accretive acquisitions, Langan tells investors in a research note. He also believes Lear's $1.4B backlog of new business provides a "sufficient cushion" to offset market and currency headwinds.